Development of invasive and growth factor-independent cell variants from primary human melanomas.
暂无分享,去创建一个
M. Herlyn | M. Herlyn | U. Rodeck | J. Jambrosic | R. Kath | L. Holland | U. Rodeck | Roland Kath | Laura Holland
[1] M. Herlyn,et al. Regulatory pathways in tumor growth and invasion. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[2] M. Herlyn,et al. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor‐derived EGF/TGF‐α , 1990, Journal of cellular biochemistry.
[3] D. Iliopoulos,et al. In vitro properties of human melanoma cells metastatic in nude mice. , 1990, Cancer research.
[4] M. Herlyn,et al. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. , 1989, The EMBO journal.
[5] D. Elder,et al. Tumor progression in the human melanocytic system. , 1989, Anticancer research.
[6] R. Kerbel,et al. Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. , 1989, Journal of the National Cancer Institute.
[7] D. Guerry,et al. Production of interleukin 1 activity by cultured human melanoma cells. , 1989, Cancer research.
[8] R. Kerbel,et al. Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. , 1988, Cancer research.
[9] B. Kwon,et al. bFGF as an autocrine growth factor for human melanomas. , 1988, Oncogene research.
[10] R. Derynck,et al. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta‐thromboglobulin. , 1988, The EMBO journal.
[11] A. Lagarde,et al. Coincidental acquisition of growth autonomy and metastatic potential during the malignant transformation of factor-dependent CCL39 lung fibroblasts. , 1988, Journal of the National Cancer Institute.
[12] I. Fidler,et al. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. , 1988, Cancer research.
[13] M. Herlyn,et al. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors , 1987, International journal of cancer.
[14] S. Ethier,et al. Importance of extended growth potential and growth factor independence on in vivo neoplastic potential of primary rat mammary carcinoma cells. , 1987, Cancer research.
[15] M. Herlyn,et al. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. , 1987, Cancer research.
[16] Y Iwamoto,et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.
[17] W. Clark,et al. Biology of tumor progression in human melanocytes. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[18] D. Rifkin,et al. Both normal and tumor cells produce basic fibroblast growth factor , 1986, Journal of cellular physiology.
[19] C. Heldin,et al. Human melanoma cell lines of primary and metastatic origin express the genes encoding the chains of platelet-derived growth factor (PDGF) and produce a PDGF-like growth factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[20] W. Clark,et al. The biologic forms of malignant melanoma. , 1986, Human pathology.
[21] G. Laurie,et al. Basement membrane complexes with biological activity. , 1986, Biochemistry.
[22] P. Nowell,et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. , 1985, Cancer research.
[23] P. Nowell,et al. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. , 1985, Journal of the National Cancer Institute.
[24] M. N. Epstein,et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. , 1984, Human pathology.
[25] V. Ling,et al. Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. , 1984, Science.
[26] P. Nowell,et al. Cytogenetics of human malignant melanoma and premalignant lesions. , 1984, Cancer genetics and cytogenetics.
[27] S. Boyce,et al. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. , 1983, The Journal of investigative dermatology.
[28] A. Richmond,et al. Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line. , 1983, Cancer research.
[29] G. Todaro,et al. Human transforming growth factor. Production by a melanoma cell line, purification, and initial characterization. , 1982, The Journal of biological chemistry.
[30] W. Clark,et al. Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. , 1980, Cancer research.
[31] C. Keysser. Neoplastic Development, Vol. 2 , 1976 .
[32] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[33] I. Fidler,et al. Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.
[34] H. Kung,et al. Expression and release of interleukin-1 by different human melanoma cell lines. , 1989, Journal of the National Cancer Institute.
[35] J. D. De Larco,et al. Ectopic peptides released by a human melanoma cell line that modulate the transformed phenotype. , 1985, Ciba Foundation symposium.
[36] M. Herlyn,et al. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. , 1984, The Journal of clinical investigation.